Kidney AI-enabled Care Transformation

Summary

In the Kidney ACTion study, CKD (Chronic Kidney Disease) patients at increased risk of progression to ESRD (End Stage Renal Disease) will be randomly assigned to either standard of care in a specialist nephrology outpatient clinic or to receiving CKD care supported by a novel AI-supported (Artificial Intelligence) software solution.

Conditions

• Chronic Kidney Diseases

Interventions

DEVICE

Kidney ACTion

AI-supported software for chronic kidney disease care

OTHER

Standard of care

Standard of care

Sponsors & Collaborators

• Fraunhofer Institut für Arbeitswirtschaft und Organisation

  collaborator UNKNOWN

• Empirica

  collaborator UNKNOWN

• IN-JET APS

  collaborator UNKNOWN

• CNET Svenska AB

  collaborator UNKNOWN

• XIGME

  collaborator UNKNOWN

• European ESKD Patients' Federation

  collaborator UNKNOWN

• Catholic University of the Sacred Heart

  collaborator OTHER

• University of Manchester

  collaborator OTHER

• Università degli studi di Verona

  collaborator UNKNOWN

• University of Leeds

  collaborator OTHER

• Roche Diagnostics International AG

  collaborator INDUSTRY

• Federación Nacional ALCER

  collaborator UNKNOWN

• Medical University of Graz

  lead OTHER

Principal Investigators

• Alexander H Kirsch, MD · Medical University of Graz

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-11-30

Primary Completion

2024-05-31

Completion

2024-10-31

Countries

• Italy
• United Kingdom

Study Locations